Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (6945)	3/14/2001 10:21:32 AM
From: wilyolvet	Respond to of 14101

imo, beckysboss on SH is dominating the dmx threads these days in terms of value added he has recently posted on the fda meetings and the indication from both the vioxx and celebrex studies is that approximately 25% of individuals withdrew from each of the studies from adverse side effects...note the difference in rates vs the 5% rate (the percentage of people that are taken off nsaid prescriptions) that has been touted by rebecca and continues to be used on the dmx site today he has two more postings that he lifted of the Merck chatline on CNBC....the postings indicate that the wheels may be falling off at Merck as vioxx aint what it was cracked up to be for anyone that hasn't been following the recent beckysboss postings on SH, jump over and click on his name and it will allow you to review his recent posts...